A chimeric haemagglutinin-based universal influenza virus vaccine boosts human cellular immune responses directed towards the conserved haemagglutinin stalk domain and the viral nucleoprotein.
收藏官方服务：
资源简介：
The authors sought to determine whether the vaccines utilized in the observer-blind, randomized placebo-controlled phase I trial (NCT03300050) could, in addition to elicit durable HA stalk specific antibodies, boost T-cell responses against HA stalk, and nucleoprotein (NP).
提供机构：
ImmPort创建时间：
2024-04-25
